rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
21
|
pubmed:dateCreated |
2009-10-30
|
pubmed:abstractText |
A novel series of pyrazolo[1,5-b]pyridazines have been synthesized and identified as cyclin dependant kinase inhibitors potentially useful for the treatment of solid tumors. Modification of the hinge-binding amine or the C(2)- and C(6)-substitutions on the pyrazolopyridazine core provided potent inhibitors of CDK4 and demonstrated enzyme selectivity against VEGFR-2 and GSK3beta.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1464-3405
|
pubmed:author |
pubmed-author:AlbertiJennifer BJB,
pubmed-author:DavisStephen TST,
pubmed-author:GriffinRobert JRJ,
pubmed-author:HassellAnne MAM,
pubmed-author:Kane-CarsonLaurie SLS,
pubmed-author:KnickVictoria BVB,
pubmed-author:PeelMichael RMR,
pubmed-author:PriceDaniel JDJ,
pubmed-author:RenoMichael JMJ,
pubmed-author:ShewchukLisa MLM,
pubmed-author:StevensKirk LKL,
pubmed-author:VealJames MJM
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5758-62
|
pubmed:dateRevised |
2011-11-2
|
pubmed:meshHeading |
pubmed-meshheading:18835709-Cyclin-Dependent Kinase 4,
pubmed-meshheading:18835709-Drug Evaluation, Preclinical,
pubmed-meshheading:18835709-Drug Screening Assays, Antitumor,
pubmed-meshheading:18835709-Glycogen Synthase Kinase 3,
pubmed-meshheading:18835709-Models, Molecular,
pubmed-meshheading:18835709-Protein Kinase Inhibitors,
pubmed-meshheading:18835709-Pyridazines,
pubmed-meshheading:18835709-Vascular Endothelial Growth Factor Receptor-2
|
pubmed:year |
2008
|
pubmed:articleTitle |
Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.
|
pubmed:affiliation |
Department of Oncology, GlaxoSmithKline, Research Triangle Park, NC 27709, USA. Kirk.L.Stevens@gsk.com
|
pubmed:publicationType |
Journal Article
|